JSPR — Jasper Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $305.33m
- $186.86m
- 36
- 19
- 88
- 45
Annual cashflow statement for Jasper Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.99 | -31.7 | -30.6 | -37.7 | -64.5 |
| Depreciation | |||||
| Non-Cash Items | 1.09 | 12.1 | -5.04 | -8.5 | 6.19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.93 | 1.3 | 1.62 | -0.649 | 5.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.97 | -18.3 | -33.7 | -45.9 | -52.1 |
| Capital Expenditures | — | — | -2.43 | -0.576 | -0.267 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -2.43 | -0.576 | -0.267 |
| Financing Cash Flow Items | — | — | 90 | 0 | -0.96 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.1 | 11.3 | 101 | 0.055 | 101 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 27.2 | -6.98 | 64.9 | -46.4 | 48.6 |